Role of the microenvironment in tumor growth and in refractoriness/resistance to anti-angiogenic therapies

被引：100

作者：

Shojaei, Farbod ^{[1
]}

Ferrara, Napoleone ^{[1
]}

机构：

[1] Genentech Inc, San Francisco, CA 94080 USA

来源：

DRUG RESISTANCE UPDATES | 2008年 / 11卷 / 06期

关键词：

Tumor angiogenesis; VEGF; Anti-VEGF; Stromal cells; CD11b+Gr1+cells; Tumor-associated endothelial cells; Endothelial progenitor cells;

D O I：

10.1016/j.drup.2008.09.001

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

Angiogenesis is critical for growth of many tumor types and the development of anti-angiogenic agents opened a new era in cancer therapy. However, similar to other anti-cancer therapies, inherent/acquired resistance to anti-angiogenic drugs may occur in cancer patients leading to disease recurrence. Recent studies in several experimental models suggest that both tumor and non-tumor (stromal) cell types may be involved in the reduced responsiveness to the treatments. The current review focuses on the role of stromal cells in tumor growth and in refractoriness to anti-VEGF treatment. (C) 2008 Elsevier Ltd. All rights reserved.

引用

收藏

页码：219 / 230

页数：12

相关论文

共 175 条

[81] VASCULAR ENDOTHELIAL GROWTH-FACTOR IS A SECRETED ANGIOGENIC MITOGEN [J].

LEUNG, DW ;

CACHIANES, G ;

KUANG, WJ ;

GOEDDEL, DV ;

FERRARA, N .

SCIENCE, 1989, 246 (4935) :1306-1309

[82] Cross-species vascular endothelial growth factor (VEGF)-blocking antibodies completely inhibit the growth of human tumor xenografts and measure the contribution of stromal VEGF [J].

Liang, WC ;

Wu, XM ;

Peale, FV ;

Lee, CV ;

Meng, G ;

Gutierrez, J ;

Fu, L ;

Malik, AK ;

Gerber, HP ;

Ferrara, N ;

Fuh, G .

JOURNAL OF BIOLOGICAL CHEMISTRY, 2006, 281 (02) :951-961

[83]

Lingen MW, 1996, LAB INVEST, V74, P476

[84] Targeting tumor-associated fibroblasts improves cancer chemotherapy by increasing intratumoral drug uptake [J].

Loeffler, Markus ;

Krueger, Joerg A. ;

Niethammer, Andreas G. ;

Reisfeld, Ralph A. .

JOURNAL OF CLINICAL INVESTIGATION, 2006, 116 (07) :1955-1962

[85] Impaired recruitment of bone-marrow-derived endothelial and hematopoietic precursor cells blocks tumor angiogenesis and growth [J].

Lyden, D ;

Hattori, K ;

Dias, S ;

Costa, C ;

Blaikie, P ;

Butros, L ;

Chadburn, A ;

Heissig, B ;

Marks, W ;

Witte, L ;

Wu, Y ;

Hicklin, D ;

Zhu, ZP ;

Hackett, NR ;

Crystal, RG ;

Moore, MAS ;

Hajjar, KA ;

Manova, K ;

Benezra, R ;

Rafii, S .

NATURE MEDICINE, 2001, 7 (11) :1194-1201

[86] ISOLATION OF A HUMAN PLACENTA CDNA CODING FOR A PROTEIN RELATED TO THE VASCULAR-PERMEABILITY FACTOR [J].

MAGLIONE, D ;

GUERRIERO, V ;

VIGLIETTO, G ;

DELLIBOVI, P ;

PERSICO, MG .

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1991, 88 (20) :9267-9271

[87] Rapid vascular regrowth in tumors after reversal of VEGF inhibition [J].

Mancuso, Michael R. ;

Davis, Rachel ;

Norberg, Scott M. ;

O'Brien, Shaun ;

Sennino, Barbara ;

Nakahara, Tsutomu ;

Yao, Virginia J. ;

Inai, Tetsuichiro ;

Brooks, Peter ;

Freimark, Bruce ;

Shalinsky, David R. ;

Hu-Lowe, Dana D. ;

McDonald, Donald M. .

JOURNAL OF CLINICAL INVESTIGATION, 2006, 116 (10) :2610-2621

[88] Vascular channel formation by human melanoma cells in vivo and in vitro:: Vasculogenic mimicry [J].

Maniotis, AJ ;

Folberg, R ;

Hess, A ;

Seftor, EA ;

Gardner, LMG ;

Pe'er, J ;

Trent, JM ;

Meltzer, PS ;

Hendrix, MJC .

AMERICAN JOURNAL OF PATHOLOGY, 1999, 155 (03) :739-752

[89] Tumour immunity: effector response to tumour and role of the microenvironment [J].

Mantovani, Alberto ;

Romero, Pedro ;

Palucka, A. Karolina ;

Marincola, Francesco M. .

LANCET, 2008, 371 (9614) :771-783

[90] Tumor-induced tolerance and immune suppression by myeloid derived suppressor cells [J].

Marigo, Ilaria ;

Dolcetti, Luigi ;

Serafini, Paolo ;

Zanovello, Paola ;

Bronte, Vincenzo .

IMMUNOLOGICAL REVIEWS, 2008, 222 :162-179

← 4 5 6 7 8 9 10 11 12 13 →